| Literature DB >> 31211023 |
Minglu Wang1, Weitao Li1, Yuying Tao1, Limei Zhao1.
Abstract
BACKGROUND: Epilepsy during pregnancy presents a unique set of challenges for pregnant women, the fetus, and the health care community. As research in this area advances rapidly, it is critical to keep up with the emerging trends and key turning points of the development of the domain knowledge. This study aimed to construct a series of science maps to quantitatively and qualitatively evaluate the intellectual landscape and research frontiers in the field of epilepsy during pregnancy research.Entities:
Keywords: Antiepileptic drugs; CiteSpace; Epilepsy; Pregnancy; Scientometrics; Visualization
Year: 2019 PMID: 31211023 PMCID: PMC6557303 DOI: 10.7717/peerj.7115
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flow chart of literature screening included in this study.
Figure 2Publication outputs related to epilepsy during pregnancy research.
(A) The number of annual publications and (B) growth trends of the top 10 countries/regions.
The top 10 countries and institutions contributing to publications in epilepsy during pregnancy research.
| Rank | Country/Region | Count | Centrality | Institute | Count | Centrality |
|---|---|---|---|---|---|---|
| 1 | US | 717 | 0.21 | University of Melbourne | 68 | 0.15 |
| 2 | England | 220 | 0.00 | Harvard University | 60 | 0.19 |
| 3 | Italy | 153 | 0.01 | University of Queensland | 59 | 0.05 |
| 4 | Australia | 137 | 0.03 | Karolinska Institution | 47 | 0.11 |
| 5 | Canada | 135 | 0.40 | Emory University | 47 | 0.10 |
| 6 | Sweden | 111 | 0.14 | Aarhus University Hospital | 42 | 0.04 |
| 7 | People’s Republic of China | 96 | 0.27 | University of Liverpool | 37 | 0.03 |
| 8 | Netherlands | 96 | 0.15 | Columbia University | 34 | 0.06 |
| 9 | Denmark | 89 | 0.54 | Sree Chitra Tirunal Institute for Medical Sciences and Technology | 27 | 0.01 |
| 10 | Turkey | 86 | 0.00 | University of California los Angeles | 26 | 0.09 |
Note:
The “count” refers to “the number of publications”.
Figure 3The distribution of countries/regions and institutions.
(A) The network map of countries/regions that involved in epilepsy during pregnancy research and (B) the network map of institutions that involved in epilepsy during pregnancy research.
The top 15 journals that published articles in epilepsy during pregnancy research (sorted by count).
| Rank | Journal title | Count | Percentage (N/2,225) | IF (2017) | Quartile in category (2017) | |
|---|---|---|---|---|---|---|
| 1 | 163 | 7.326 | 5.067 | Q1 | 47 | |
| 2 | 135 | 6.067 | 2.600 | Q2 | 24 | |
| 3 | 91 | 4.090 | 2.839 | Q2 | 20 | |
| 4 | 77 | 3.461 | 8.055 | Q1 | 77 | |
| 5 | 59 | 2.652 | 2.491 | Q3 | 20 | |
| 6 | 53 | 2.382 | 2.398 | Q3 | 18 | |
| 7 | 41 | 1.843 | 1.665 | Q4 | 15 | |
| 8 | 35 | 1.573 | 2.766 | Q1 | 12 | |
| 9 | 26 | 1.169 | 1.544 | Q4 | 13 | |
| 10 | 26 | 1.169 | 2.580 | Q2 | 13 | |
| 11 | 24 | 1.079 | 5.515 | Q1 | 16 | |
| 12 | 23 | 1.034 | 3.125 | Q2 | 13 | |
| 13 | 21 | 0.944 | 1.500 | Q4 | 11 | |
| 14 | 18 | 0.809 | 2.362 | Q3 | 9 | |
| 15 | 17 | 0.764 | 3.126 | Q2 | 9 |
Notes:
The “count” refers to “the number of publications”.
The H-index belongs to the set of documents published by the journal on the topic.
In the column of quartile in category in the Table 1, the unspecified marked journals are of the same category of Clinical Neurology, that journals are labeled as “*,” “**,” “***,” “****,” and “*****” belong to the category of Behavioral Sciences, Multidisciplinary Sciences, Reproductive Biology, Pediatrics, and Neurosciences, respectively.
Figure 4The dual-map overlay of journals related to epilepsy during pregnancy research.
The graphics corresponding to the citing journals and the cited journals were located on the left and right of the network map, respectively. The blue labels represent the disciplines covered by the journal, the lines on the map start from the left and end on the right, representing the citation links. The ellipses of different size in the graph show the number of articles on their vertical axis and the number of authors on their horizontal axis.
Figure 5The distribution of authors contributed to epilepsy during pregnancy research.
(A) The network map of productive authors and (B) The network map of co-cited authors.
The top 10 authors and co-cited authors contributed to publications in epilepsy during pregnancy research.
| Rank | Author | Count | Centrality | Co-cited author | Citation counts | Centrality |
|---|---|---|---|---|---|---|
| 1 | Pennell PB | 48 | 0.05 | Tomson T | 445 | 0.00 |
| 2 | Tomson T | 44 | 0.06 | Meador KJ | 305 | 0.00 |
| 3 | Vajda FJE | 29 | 0.00 | Holmes LB | 284 | 0.17 |
| 4 | Meador KJ | 28 | 0.03 | Pennell PB | 232 | 0.01 |
| 5 | Thomas SV | 28 | 0.01 | Vajda FJE | 219 | 0.01 |
| 6 | O’Brien TJ | 25 | 0.01 | Harden CL | 215 | 0.00 |
| 7 | Christensen J | 24 | 0.02 | Morrow J | 215 | 0.07 |
| 8 | Graham J | 23 | 0.01 | Adab N | 204 | 0.18 |
| 9 | Boylan GB | 20 | 0.01 | Sabers A | 183 | 0.01 |
| 10 | Sabers A | 19 | 0.02 | Volpe JJ | 164 | 0.01 |
Note:
The “count” refers to “the number of publications”.
Figure 6The analysis of references involved in epilepsy during pregnancy research.
(A) The network map of co-citation reference, (B) the network map of co-citation clusters, and (C) the timeline view of co-citation clusters.
Top 10 co-cited references sorted by the number of citations.
| Rank | Co-citation counts | Centrality | Cited reference | Author, year, journal, volume, and pages | Cluster # |
|---|---|---|---|---|---|
| 1 | 162 | 0.02 | Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register | Morrow J, 2006, J Neurol Neurosur Ps, V77, P193 | 1 |
| 2 | 137 | 0.01 | Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry | Tomson T, 2011, Lancet Neurol, V10, P609 | 0 |
| 3 | 106 | 0.02 | The teratogenicity of anticonvulsant drugs | Holmes LB, 2001, New Engl J Med, V344, P1132 | 1 |
| 4 | 97 | 0.03 | Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs | Meador KJ, 2009, New Engl J Med, V360, P1597 | 0 |
| 5 | 92 | 0.05 | The longer-term outcome of children born to mothers with epilepsy | Adab N, 2004, J Neurol Neurosur Ps, V75, P1575 | 1 |
| 6 | 86 | 0.02 | Comparative safety of antiepileptic drugs during pregnancy | Hernandez-diaz S, 2012, Neurology, V78, P1692 | 0 |
| 7 | 80 | 0.00 | Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study | Meador KJ, 2013, Lancet Neurol, V12, P244 | 0 |
| 8 | 76 | 0.02 | Antiepileptic drug use of women with epilepsy and congenital malformations in offspring | Artama M, 2005, Neurology, V64, P1874 | 1 |
| 9 | 74 | 0.03 | Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study | Wide K, 2004, Acta Paediatr, V93, P174 | 1 |
| 10 | 73 | 0.02 | Increased rate of major malformations in offspring exposed to valproate during pregnancy | Wyszynski DF, 2005, Neurology, V64, P961 | 1 |
Top 11 largest clusters of co-cited references (size sorting).
| Cluster ID | Size | Silhouette | Mean (year) | Label (LLR) | Label (TF*IDF) | Label (MI) |
|---|---|---|---|---|---|---|
| #0 | 111 | 0.792 | 2011 | Neonatal seizures | Antiepileptic drugs | Anorexia |
| #1 | 83 | 0.770 | 2001 | Fetal malformations | Psychomotor development | Teratogenic |
| #2 | 60 | 0.974 | 2010 | Neonatal seizures | Neonatal seizures | Epilepsy monitoring |
| #3 | 49 | 0.994 | 1998 | Dentate gyrus | Preterm infants | Androgen |
| #4 | 48 | 0.873 | 2005 | Pharmacokinetics | Malformations | Immunoassay |
| #5 | 46 | 0.936 | 1996 | Women | Teratogenesis | Cohort studies |
| #6 | 42 | 0.778 | 1999 | Pregnancy outcomes | Educational need | Substitution study |
| #7 | 29 | 0.948 | 2006 | Histone deacetylase | Valproic acid | Glutamate |
| #8 | 23 | 0.997 | 1998 | Valpromide | Teratogenicity | Epilepsy monitoring |
| #10 | 16 | 0.994 | 1997 | Teratogenesis | Questionnaire | Epilepsy monitoring |
| #11 | 16 | 0.955 | 1996 | Fetal valproate syndrome | Neuro development | Epilepsy |
Notes:
Mean (year) represents the average publication time of the literature contained in this cluster.
LLR (Log-likelihood ratio) is one of the clustering label word extraction algorithm.
TF-IDF (Term frequency–inverse document frequency) is a commonly used weighting techniques for information retrieval and data mining, this algorithm can generate cluster labels based on the title of the citing document.
MI (Mutual information) is also one of the clustering label word extraction algorithm.
Clusters are referred in terms of the labels selected by log-likelihood ratio test method (LLR) in this study.
Cited and citing references of Cluster #0 neonatal seizures.
| Cluster #0 neonatal seizures | |||
|---|---|---|---|
| Cited references | Citing articles | ||
| Cites | Author (year) journal, volume, page | Coverage (%) | Author (year) title |
| 134 | Tomson T (2011) Lancet Neurol, V10, P609 | 18 | Eadie, MJ (2014) |
| 97 | Meador KJ (2009) New Engl J Med, V360, P1597 | 15 | Tomson, T (2012) Teratogenic effects of antiepileptic drugs |
| 83 | Hernandez-diaz S (2012) Neurology, V78, P1692 | 10 | Borthen, I (2012) Pregnancy complications in patients with epilepsy |
| 78 | Meador KJ (2013) Lancet Neurol, V12, P244 | 9 | Hill, DS (2010) Teratogenic effects of antiepileptic drugs |
| 62 | Christensen J (2013) Jama-J AM Med Assoc, V309, P1696 | 9 | Holmes, LB (2012) Newer anticonvulsants: lamotrigine, topiramate and gabapentin |
| 60 | Meador K (2008) Epilepsy Res, V81, P1 | 7 | Bobo, WV (2015) Trends in the use of antiepileptic drugs among pregnant women in the us, 2001-2007: a medication exposure in pregnancy risk evaluation program study |
| 52 | Molgaard-nielsen D (2011) Jama-J AM Med Assoc, V305, P1996 | 7 | Vajda, FJE (2014) The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy |
| 51 | Jentink J (2010) New Engl J Med, V362, P2158 | 7 | Voinescu, PE (2017) Delivery of a personalized treatment approach to women with epilepsy |
Note:
Cluster label terms are bold.
Cited and citing references of cluster #1 fetal malformations.
| Cluster #1 fetal malformations | |||
|---|---|---|---|
| Cited references | Citing articles | ||
| Cites | Author (year) journal, volume, page | Coverage (%) | Author (year) title |
| 161 | Morrow J (2006) J Neurol Neurosur Ps, V77, P193 | 17 | Pennell, PB (2004) Pregnancy in women who have epilepsy |
| 106 | Holmes LB (2001) New Engl J Med, V344, P1132 | 13 | Hill, DS (2010) Teratogenic effects of antiepileptic drugs |
| 92 | Adab N (2004) J Neurol Neurosur Ps, V75, P1575 | 13 | Ozyurek, H (2010) Effect of prenatal levetiracetam exposure on motor and |
| 76 | Artama M (2005) Neurology, V64, P1874 | 12 | Ikonomidou, C (2010) Antiepileptic drugs and brain development |
| 74 | Wide K (2004) Acta Paediatr, V93, P174 | 12 | Kaplan, PW (2004) Reproductive health effects and teratogenicity of antiepileptic drugs |
Note:
Cluster label terms are bold.
Figure 7Top 25 keywords with the strongest citation bursts.